Improving care for heart stent patients on blood thinners
Part of Heart & circulation clinical trials.
This study aims to improve how doctors monitor and guide treatment for people with heart disease who have had a stent placed. It focuses on finding the best ways to manage blood-thinning medications to reduce risks of bleeding and clotting.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You have been diagnosed with acute coronary syndrome (a heart emergency) and have received at least one drug-eluting stent (a tube to keep your artery open).
- You are considered to be at high risk for bleeding, based on specific criteria your doctor can check.
- Your doctor thinks you can safely take two blood-thinning medicines (aspirin plus either clopidogrel or ticagrelor) for at least 12 months.
- You cannot be allergic to aspirin, clopidogrel, or ticagrelor, and you must not have had a major heart or bleeding event during this hospital stay.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a shorter, gentler blood thinner plan after getting a heart stent. It is designed for people who have had a heart attack or unstable angina and who are at higher risk of bleeding, to help prevent future heart problems with less bleeding risk.
This study tests whether a shorter course of blood-thinning medication after heart stent placement is safer and just as effective for older adults. It aims to reduce bleeding risks while still preventing heart attacks and strokes.
This study tests whether a personalized score (OPT-CAD) can help decide the best time to stop or reduce blood-thinning medication in people who have had a heart attack and a stent placed. It aims to balance preventing future heart issues while lowering the risk of bleeding.
This trial studies ways to reduce bleeding in people after a stent procedure (PCI) who have been taking two anti-platelet medicines (aspirin plus prasugrel or ticagrelor) for a set amount of time. It may help find a safer plan for preventing blood clots while lowering bleeding risk.
This trial tests a new way of taking blood thinners after getting a stent. Instead of staying on two blood thinners for a long time, you switch earlier to just one (ticagrelor). This might reduce bleeding risks while still protecting against heart problems.
This study tests a new type of stent (a small mesh tube that opens a blocked heart artery) designed to reduce bleeding risks in people who are more likely to bleed. If you are having a coronary angioplasty and are at high risk of bleeding, this might be a good option to discuss with your doctor.
Hear when a new Acute Coronary Syndrome (ACS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.